Welcome to our dedicated page for Ingles Mkts news (Ticker: IMKTA), a resource for investors and traders seeking the latest updates and insights on Ingles Mkts stock.
News for Ingles Markets, Incorporated (NASDAQ: IMKTA) focuses on its role as a regional supermarket operator in the southeastern United States and on developments that affect its grocery and retail operations. The company describes itself as a leading grocer with operations in six southeastern states, headquartered in Asheville, North Carolina, and operating close to 200 supermarkets supported by neighborhood shopping centers and a fluid dairy facility.
On this page, readers can follow Ingles Markets news that includes quarterly and annual earnings releases, where the company reports net sales, gross profit, operating and administrative expenses, interest expense, net income, and earnings per share for its Class A and Class B common stock. These releases often discuss capital expenditures, total debt, and selected balance sheet items, as well as commentary from the company’s leadership on operating conditions.
Ingles also issues regular announcements about quarterly cash dividends on its common stock, specifying dividend rates for each share class and record and payment dates. Other news items may cover corporate governance and regulatory developments, such as amendments to the company’s bylaws or changes in board composition, as disclosed in related SEC filings.
Recent news has highlighted the operational impact of Hurricane Helene on Ingles’ stores and headquarters area in western North Carolina, including temporary store closures, impairment losses, and cleanup and repair efforts. Investors and observers use these updates to understand how external events and regional economic conditions influence the company’s financial performance and store network. For ongoing coverage of IMKTA news, this feed aggregates company press releases and related disclosures in one place.
Ingles Markets (NASDAQ: IMKTA) is enhancing vaccination accessibility for its distribution center and office associates through on-site clinics. These clinics aim to facilitate the vaccination process for essential workers while allowing them to discuss the vaccine with pharmacists. CFO Ron Freeman emphasized the company's dedication to employee and customer protection during the pandemic. Additionally, Ingles is incentivizing vaccination by offering paid time off for associates to complete their vaccination series.
Ingles Markets (IMKTA) announces new initiatives to support the vaccination of its associates. Full-time employees will receive 10 hours of paid time off, while part-time employees will receive 5 hours upon becoming fully vaccinated against COVID-19. Additionally, Ingles has set up vaccination clinics at its Black Mountain, North Carolina headquarters and distribution center, as well as offering COVID-19 vaccines in its pharmacies across North Carolina, Georgia, South Carolina, and Tennessee. This effort underscores Ingles' commitment to employee health and community wellness.
Ingles Markets, Incorporated (NASDAQ: IMKTA) has declared a cash dividend of $0.165 per share on Class A Common Stock and $0.15 per share on Class B Common Stock. This equates to an annual rate of $0.66 for Class A and $0.60 for Class B shares. The dividends are scheduled for payment on April 15, 2021, to shareholders on record as of April 8, 2021.
The company, headquartered in Asheville, North Carolina, operates 198 supermarkets across six southeastern states.
Ingles Markets (NASDAQ: IMKTA) will host a job fair on March 29th from 10 am to 6 pm at its Distribution Center in Black Mountain, NC, aiming to fill over 50 full-time positions across various departments. The company offers competitive pay, especially for forklift operators and order selectors, along with benefits like health insurance, paid time off, and 401k matching. Interested candidates may RSVP or walk in to apply. This initiative emphasizes Ingles' commitment to supporting its retail operations by enhancing workforce availability.
Ingles Markets, Incorporated (NASDAQ: IMKTA) has authorized a share repurchase program for up to 2 million shares of its Class A and Class B Common Stock. As of March 19, 2021, the company had approximately 14.2 million Class A shares and 6.0 million Class B shares outstanding. The program will utilize existing cash, operational cash flow, and financing sources. Repurchases may occur through open market purchases and private transactions, and the timing will depend on various market conditions.
Ingles Markets (NASDAQ: IMKTA) reported a 10.4% increase in net sales to $1.19 billion for the quarter ending December 26, 2020, compared to $1.08 billion in the same period in 2019. The company achieved a net income of $53.8 million, significantly up from $17.7 million the previous year. Gross profit rose to $314.2 million, or 26.4% of sales. Despite higher operating expenses due to pandemic safety measures, the company reduced its debt to $587.9 million from $850 million. Earnings per share were $2.73 (basic) compared to $0.90 the prior year.
Ingles Markets, Incorporated (NASDAQ: IMKTA) has declared a cash dividend of $0.165 per share for Class A Common Stock and $0.15 per share for Class B Common Stock. This results in an annual dividend rate of $0.66 for Class A and $0.60 for Class B. The dividends are set to be paid on January 14, 2021, to all shareholders of record on January 7, 2021. The company operates 197 supermarkets and maintains a strong presence across six southeastern states.
The FDA has granted its first emergency use authorization for a COVID-19 vaccine, a milestone welcomed by Ingles Markets (NASDAQ: IMKTA). The company is preparing to administer the vaccine, prioritizing high-risk populations as defined by the CDC. CFO Ron Freeman emphasized the role of Ingles pharmacists in community health during this initiative. Ingles Markets operates 197 supermarkets across six southeastern states and aims to efficiently communicate with patients about the vaccine rollout.
Ingles Markets (NASDAQ: IMKTA) reported strong financial results for the fourth quarter and fiscal year ended September 26, 2020. Net sales reached $1.20 billion for Q4, a rise of 11.3% year-over-year, while annual sales totaled $4.61 billion, marking a 9.7% increase. Net income surged to $57.9 million for Q4 and $178.6 million for the fiscal year. However, operating expenses rose due to pandemic-related safety measures. The company reduced total debt from $852.2 million to $605.5 million, reflecting strategic refinancing efforts.
Ingles Markets (NASDAQ: IMKTA) is partnering with the U.S. Department of Health and Human Services to administer the upcoming COVID-19 vaccine. Once approved, Ingles Pharmacies will receive direct allocations of the vaccine. The company aims to ensure safe and convenient vaccine administration for its communities, continuing its commitment to public health. Ingles has already set records in flu vaccinations during the pandemic and will maintain heightened safety measures to protect customers.